Aptose Biosciences Inc.
APTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $9 | $37 | $39 |
| Short-Term Investments | $0 | $0 | $10 | $40 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $0 | $0 |
| Total Curr. Assets | $10 | $12 | $50 | $82 |
| Property Plant & Equip (Net) | $1 | $1 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $13 | $51 | $83 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $6 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $3 | $4 |
| Total Curr. Liab. | $4 | $15 | $12 | $8 |
| LT Debt | $10 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $10 | $1 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $15 | $16 | $13 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $457 | $445 | $438 | $437 |
| Retained Earnings | -$541 | -$516 | -$464 | -$423 |
| AOCI | -$4 | -$4 | -$4 | -$4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$5 | -$3 | $38 | $74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10 | $13 | $51 | $83 |
| Net Debt | $4 | -$9 | -$37 | -$39 |